ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies

/PRNewswire/ -- As the tissue engineering and regenerative medicine industry has shown tremendous potential in clinical practices in recent years worldwide,...

Related Keywords

Mexico ,Germany ,Japan ,Shanghai ,China ,United States ,Hong Kong ,Singapore ,Boston ,Massachusetts ,Zhang Xin ,Beijing ,Switzerland ,Nanjing ,Jiangsu ,Shandong ,America ,David Bichara ,Tilmann Bur ,Technology Parks Corporation ,Co Don Ag Cnw Df Acquisition ,Co Don ,Harvard Medical School ,Biotechnologies Ltd ,Research Development ,Faculty Of Medicine At Utrecht University ,For Company ,Health Sciences Authority ,Shanghai Industrial Investment Holdings Co Ltd ,European Medicines Agency ,Shanghai Pharmaceuticals Holding ,Research Steering Committee At Vericel ,Orthopedic Device Company ,Live Biotechnologies ,Shanghai Healthcare Capital ,Indaco Capital ,Jiuyo Capital ,Shanghai Industrial Investment ,Shanghai Pharma ,Financing Fuel Relive ,Hong Kong Science ,South America ,Middle East ,Regenerative Medicine ,Utrecht University ,Harvard Medical ,Research Steering Committee ,Device Company Limited ,Development Director ,Science Advisory Board ,Sports Medicine ,